174456-38-3

Basic information

• Product Name: 2'-(2,3-di-O-Acetyl-β-D-glucopyranosyloxy)-6'-hydroxy-3-(5-benzo[b]-furanyl)propiophenone
• Synonyms: 2'-(2,3-di-O-Acetyl-β-D-glucopyranosyloxy)-6'-hydroxy-3-(5-benzo[b]-furanyl)propiophenone
• CAS NO: 174456-38-3
• Molecular Weight: 528.513
• Mol File: 174456-38-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2'-(2,3-di-O-Acetyl-β-D-glucopyranosyloxy)-6'-hydroxy-3-(5-benzo[b]-furanyl)propiophenone(CAS DataBase Reference)
• NIST Chemistry Reference: 2'-(2,3-di-O-Acetyl-β-D-glucopyranosyloxy)-6'-hydroxy-3-(5-benzo[b]-furanyl)propiophenone(174456-38-3)
• EPA Substance Registry System: 2'-(2,3-di-O-Acetyl-β-D-glucopyranosyloxy)-6'-hydroxy-3-(5-benzo[b]-furanyl)propiophenone(174456-38-3)

Safety Data

• Hazardous Substances Data: 174456-38-3(Hazardous Substances Data)

Upstream product

• 174456-59-8 2'-(2,3-di-O-acetyl-4,6-O-benzylidene-β-D-glucopyranosyloxy)-6'-acetoxy-3-(5-benzo-[b]furanyl)propiophenone 
• 174456-58-7 2'-(4,6-O-benzylidene-β-D-glucopyranosyloxy)-6'-hydroxy-3-(5-benzo[b]furanyl)propiophenone 
• 174456-32-7 2'-(β-D-glucopyranosyloxy)-6'-hydroxy-3-(5-benzo[b]-furanyl)propiophenone 
• 174456-60-1 2'-(2,3-di-O-acetyl-4,6-O-benzylidene-β-D-glucopyranosyloxy)-6'-hydroxy-3-(5-benzo[b]furanyl)propiophenone 

Downstream Products

• 174456-32-7 2'-(β-D-glucopyranosyloxy)-6'-hydroxy-3-(5-benzo[b]-furanyl)propiophenone 

Relevant articles and documents

Propiophenone derivative and processes for preparing the same

A propiophenone derivative the formula ?I!: STR1 wherein R' is a lower alkanoyl group and R" is a hydrogen atom, or R' is a hydrogen atom and R" is a lower alkoxycarbonyl group, or a pharmaceutically acceptable salt thereof. Said compounds have excellent

Propiophenone derivative and a process for preparing the same

A propiophenone derivative of the formula ?I!: STR1 wherein X is O, S or methylene, OY is a protected or unprotected OH, Z is β-D-glucopyranosyl or 4-O-(α-D-glucopyranosyl)-β-D-glucopyranosyl or wherein one or more hydroxy groups of these groups may optionally be acylated, and the dotted line means the presence or absence of a double bond, or a pharmaceutically acceptable salt thereof. Said compounds have excellent hypoglycemic activity so that they are useful in the prophylaxis or treatment of diabetes.